Parabolic

[Parabolic @Parabolicone]

Anyone STILL wondering what $TXTM really is? Here is what it is.

TXTM is a compounding force. It holds compounding biological assets, compounding seed-multiplication programs, compounding distribution avenues, compounding bioavailability advantages, compounding tissue-culture scalability driven by deep human capital, and compounding geopolitical networks through BRICS and the G20. In a bifurcated global economy, TXTM is engineered for multidirectional growth. The company is built on diversification , not dependent on any single market, any single customer base, or any single technology. Every pillar reinforces the next. Every asset creates another. TXTM is structured to expand, replicate, and scale across borders, across sectors, and across economic regimes.

And that is just the business model. What is emerging now is the clearest signal yet: all capital inputs and outputs , every investment, every return cycle, and every financial conduit , will be constructed on the same compounding, replicating, high-return, stable-equity platform. TXTM is positioning itself not merely to grow, but to multiply.

TXTM will deploy traditional financial instruments as old and proven as the markets themselves , with RWA at the core, while simultaneously leveraging the most advanced technologies on earth. The fastest blockchain networks, real-time smart contracts, instant settlement, and full supply-chain reconciliation will operate in unison. TXTM will bridge legacy finance with frontier innovation, merging stability with velocity, verification with automation, and real-world assets with programmable global liquidity.

The company will then diversify the end product and distribute it across multiple financial listing platforms, ensuring worldwide accessibility, multi-jurisdictional liquidity, and an ever-expanding global investor base. TXTM is building a system designed to scale, accelerate, and endure.

The common theme across all of these systems is disciplined diversity, strategic leveraging, intelligent hedging, and built-in redundancy, all scaled into a world-class business model.

THIS is what @Dr_Jamaloodeen @MrDylonDuPlooy Dr H and the "silent ones" that are the "we" that have planned this across generations and we, the remora will benefit . We are fortunate to be right here, right now. This time will never come again. Give thanks that you found out before the rest of the billions on this planet did. I know I am.

GLTU.

[Parabolic @Parabolicone]

So.. you switched AI and it's still trash.
Time to do some old school REAL DD.
AI doesn't have a foundation in this ticker.
The tech is too advanced and literally no one has combined all of these technologies in the way this company has , ever.

So save me the shenanigans. I've done the work. Very few have done more than me and very few have the experience of helping and showing others how to find the real answers.
So do yourself a favor. Take your time and learn the right way. Or.. move on.
GLTU

[Parabolic @Parabolicone]

Also for you to say that human capital is "interpretation " is utter ignorance in the face a a balance sheet that shows value that has literally built on it. $600 MILLION and counting.
You may want to find another AI llm to use , or maybe up your plan because I can beat this on all day.

[Parabolic @Parabolicone]

@gostanos @aplaceroftiles @bigred993 @Dr_Jamaloodeen @BankXRP You're creating a box that doesn't exist.

[Parabolic @Parabolicone]

@gostanos @aplaceroftiles @bigred993 @Dr_Jamaloodeen @BankXRP And your position also. If you fully understood what I wrote is..

They don't need it

[Parabolic @Parabolicone]

I'll be even more specific so you get it.
Which filing did you read?
Which name is at the top of it?

PROTEXT MOBILITY

The filing itself answers this. Note 5 is included inside ProText Mobility’s own Q1 disclosure, under the heading “Strategic Tokenization Initiative and Pilot Program.” It states that the Company’s President and Chief Executive Officer, in his personal capacity and through Leeds Investments and its assigns, entered into a pilot-program Letter of Intent with ABSA Bank in South Africa.

The filing also says the initiative is being conducted outside the Company, but that management believes the expertise gained could be strategically beneficial to TXTM, including future opportunities involving tokenization of real-world assets held or developed by TXTM.

That is where the human-capital point matters. TXTM is not operating like a traditional asset-heavy farm. The business model is being built through intellectual property, seed genetics, financing support, shareholder alignment, and strategic relationships contributed or facilitated by ownership. The Company has disclosed significant seed inventory, owner-provided credit support, owner-executed share purchases, and a debt-light structure. Those are not random facts. They show ownership using capital, expertise, relationships, and legally structured agreements to build value around the Company.

So the point is simple: if the ABSA-related initiative had no factual relevance to TXTM, there would be no reason for the Company to include it in its official disclosure notes. The disclosure does not say ABSA entered into a direct agreement with TXTM. But it does state that the initiative is relevant enough to TXTM’s strategy for management to disclose it in the Company’s filing, especially because TXTM’s model depends heavily on ownership-driven human capital, relationships, and assets being structured for the Company’s benefit.

So again. This shows you have not yet completed your proper due dillegence.
This is not the type of company you can come off the bench and understand. It is far more complex and advanced than you realize.
The ABSA layer is just that, a structural layer on top of a highly advanced biological asset /acquisition/banking model that will take you much more time to understand and far more information than you will find on a x chat.

[Parabolic @Parabolicone]

Apparently not throughly enough. You may want to start with company structure, ownership. HUMAN CAPITAL which properly establishes the link. Simply too many references to point to here . So im personally very comfortable with you not understanding your question has indeed been answered. Good luck with you're Due diligence. Might wanna start oh. Say 2 or 3 filings back to get the full picture

[E Woo @TXTM4life]

@RippleXrpie Did you say global??

https://t.co/SJKp8Xlwmc

[Parabolic @Parabolicone]

Lol you wish the "questions " make me uncomfortable. Oh to the contrary, they provide an exercise in affirmation.
Your "questions" show me that you lack foundational knowledge of the company and have lazily glanced over what has been disclosed and rushed to judgment in a biased lens.

The company does not need your approval and its frankly irrelevant. Multiple mischaracerizations you have made here prove that. You have MUCH to learn here.The company cannot give you the ability to comprehensively review the filings, nor bless you with the intellect to comprehend them. So I'll leave you on this merry-go-round of false flags and strawman arguments.
Its been a pleasure. Thank you for this little exercise reminding me that my due dillegence is indeed correct. I come here from time to time to see if anything challenging is worth my input. Unfortunately this too has failed to raise any concerns or doubts.

[Parabolic @Parabolicone]

So.... now we are moving from the misapplication of facts over to allegations and insinuations of self-dealing? You are quite the character, and at this point, I am convinced your intent is nefarious at its core.

First of all, the seed multiplication program and seed injections occurred after the Caveat Emptor designation. So if you are truly astute in regulatory controls and oversight, then you should understand that the OTC Markets would not have released the company from CE status without verifying that the company, in fact, had a viable business model.

If you understand that, then you must also understand that the seeds were actually implemented and that these contracts were executed post-CE designation. The multiplication program, in fact, occurred while the company was under CE status, and OTC Markets subsequently released the company while these ongoing transactions were taking place.

So I would advise you to tread very carefully with your insinuations of self-dealing when you clearly lack an understanding of how this company actually operates and are accusing management of lacking internal controls. Those are serious allegations, and factually, they are incorrect.

They have been disproven repeatedly as the company continues to operate year after year, implementing this multiplication program and executing official LOIs, which are clear indications that the company is abiding by legal contractual obligations and proper business practices.

I would also add that the company’s filings contain documented financial agreements and relationships with major banking and institutional entities that you are conveniently ignoring in your self-dealing narrative. Major Banks the filings are not owned by Dr. J nor any of the other billion-dollar institutions and counterparties disclosed in the filings. These are independent entities operating within formal legal and financial frameworks.

Your insinuation that every disclosed transaction somehow constitutes “self-dealing” demonstrates either a profound misunderstanding of corporate structuring or a deliberate attempt to misrepresent the facts. Emerging companies routinely utilize affiliated entities, strategic partnerships, financing vehicles, and legally structured corporate relationships to expand operations, secure funding, and build infrastructure. That is not unusual, improper, or illegal. It is a standard practice throughout corporate history.

What actually matters is whether those relationships are disclosed, contractually documented, legally structured, and transparently reflected in the filings. In this case, they are. The filings themselves establish that these agreements, obligations, and counterparties are being formally documented and disclosed as part of the company’s ongoing operations.

You really need to take the time to read and understand the filings in their entirety before making reckless public insinuations regarding fraud, self-dealing, or a lack of internal controls. Those are serious allegations, and the factual record simply does not support the narrative you are attempting to construct.

[Parabolic @Parabolicone]

Well Done!!👏👏👏👏 well,except there's one little problem with your thesis. Actually, a big one. It shows that while you're "asking" due diligence questions, your ability either to comprehend or do critical research is severely lacking. And you're missing critical details. While your statement on the surface seems to be authoritative, You've missed one critical thing, and you would have noticed it you had actually read each of the filings.

Each year, during the seed multiplication program, our entire inventory is taken off of the books. And given to the grower in return a new generation of seeds will enhance genetics a return to us. With the also, additional seeds from The Good Doctor. So you see your entire statement falls flat on its face .

The seeds never "spoil" because we don't maintain them in inventory.

This is about rotation of the seeds with the part is that the new genetic modifications that can only be done by nature with enhanced winterization frost resistance, and all of the other aspects that if you have read closely have been added over the years have actually increased it from that baseline amount.

So again, the questions you're asking are undermined. So please take the time to read the contract that is in the filing. To read each and every year to actually see how the cultivation and the process goes forth.

Because everything that I've said here is entirely viable. Context matters. Details matter.
I'm not trying to be combative here, but you should refrain from making authoritive statements that you are framing as fact when they lack critical details and are not actually "questions ".

[Parabolic @Parabolicone]

This is pretty hilarious, actually. You’re asking the company to publish IFRS 2022 & 2023 audits, years PRIOR to the seed multiplication program, prior to the seed improvements, and prior to any announcements regarding an uplisting, which would also require recent financial statements to be released. What value would that hold? None.

You then make the claim that no one has seen the seeds, even though any investor here knows we didn’t “grow” the seeds ourselves.

The seeds did not fall from heaven. They necessarily came from a source that, due to regulations you seem to misunderstand, would itself have to meet regulatory and compliance standards. Therefore, the seeds have been "seen,".

They have been seen by the relevant government authorities involved in issuing licenses and overseeing the program.

If the "grower" holds an FDA-related license and we intend to supply seeds to that entity, then the source and handling of those seeds would necessarily be subject to regulatory scrutiny, documentation requirements, traceability standards, compliance verification, and chain-of-custody requirements. In other words, the assets and their origin would not simply exist in a vacuum without oversight or validation.

If you doubt any of that, then you likely lack an understanding of asset validation, chain of custody requirements, and the broader regulatory framework involved. Either those points were intentionally omitted from your argument, or they were overlooked due to a misunderstanding of the process.

Either way, the argument does not make much sense.

The company will release audits when it determines the timing is appropriate. The filings have already stated that the company intends to release them. So standing on a soapbox demanding them now feels more like an afterthought than a substantive argument.

Why do you think the company announced an estimated value range for the seeds four years ago?

Because they likely already had an internal basis for that valuation from their own records. The remaining step would be to formally validate and reflect that value on TXTM books at the appropriate time.

[PROTEXT MOBILITY INC. $TXTM @ProtextP]

Protext Mobility Inc. $TXTM

🔥EXECUTION MODE: ACTIVE🟢

No Noise.
No Delays.
Only Progress.

Every Filing.
Every Disclosure.
Every Strategic Move.

$TXTM Is Being Aligned — In Real Time — With The Standards Of The Next Tier.

This Isn’t A Narrative.
This Is Infrastructure Coming Online.

📈 The Gap Isn’t Closing — It’s Being Eliminated.

📊 POSITIONING IS EVERYTHING

By The Time Uplisting Is Complete…
The Asymmetry Is Gone.

What’s Being Built Right Now:
✔ Governance
✔ Transparency
✔ Institutional Readiness

This Is The Phase Where:
Information Exists
Proof Is Forming
Attention Is Still Low

Smart Capital Doesn’t Chase Confirmation — It Positions Before It.

$TXTM Is In That Window.

🧾 DISCIPLINE DEFINES CREDIBILITY

EDGAR Filings.
8-K Disclosures.
Insider Transparency.

These Aren’t Boxes Being Checked
They’re Market Signals.

Signals Of Structure.
Signals Of Intent.
Signals Of Institutional Alignment.

This Is How Serious Companies Communicate.

🌍 BUILT FOR WHAT COMES NEXT

Not For Today’s Attention.
Not For Short-Term Narrative.

Built For:
➡ Institutional Capital
➡ Higher Exchange Standards
➡ Scalable Market Participation

Every Move Is Calculated.

Momentum Isn’t Being Chased —
It’s Being EngineERED.

⚠️ WATCH THIS PHASE CAREFULLY

Because This Is Where The Shift Happens.

Structure → Recognition
Execution → Attention
Positioning → Demand

Filings Are Live.
The Framework Is Advancing.
The Market Hasn’t Fully Reacted — Yet.

It Always Does.

The Only Variable Left Is Timing.

Be Early.
Or Explain Why You Weren’t.

$TXTM

#TXTM #Uplisting #Execution #Growth #Positioning

[WolfOfOTC @WolfOfOTC]

Today’s updated Form 4 matters more than people realize and thy need to understand the WHOLE picture of it.

The first Form 4 filed 3 days ago already confirmed Dr. Ahmed Jamaloodeen’s beneficial ownership tied to TXTM. But today’s updated filing goes further by adding the common stock transactions and showing the proper reported dates:

Common Stock added/reported:

12/31/2024 - 89,866,874 shares
09/30/2025 - 7,170,075 shares
04/07/2026 - 45,212,287 shares

Total beneficial ownership now shown: 254,749,236 common shares

And let’s not ignore the most important part:

Back when the reverse merger happened in 2022, the filing shows the Series A Preferred and Series D Preferred were acquired on 06/03/2022.

Those preferred shares have conversion rights.

Yet after all these years, through the CE, through the attacks, through the false accusations, through the constant “pump and dump” claims… nothing was converted, dumped, or used against shareholders.

That completely matters.

For almost three years, people blamed Dr. J for things tied to the CE and acted like this was some insider scheme. But this filing tells a very different story. If the intent was to pump, convert, dump, and walk away, the structure was there years ago.

But that did not happen.

No conversion of the Series A.

No conversion of the Series D.

No insider dumping.

No abusive preferred-share exit.

Instead, Dr. J remained aligned with the company, continued building, and is now formally reporting the ownership structure in a way that brings everything into the light.

This is exactly why filings matter more than rumors.

People can have opinions. But falsely accusing someone of running a pump and dump when the actual filings show no preferred conversion, no insider dump, and years of continued ownership is a completely different issue.

At some point, people need to sit down and let the filings speak.

This updated Form 4 is not just a filing.

It is a timeline.

It shows ownership.

It shows restraint.

It shows alignment.

And it directly contradicts the narrative that certain people have pushed for years.

TXTM is entering a different chapter now. The company has been cleaning up, documenting, reporting, and aligning disclosure practices with SEC standards. This is what that looks like.

Not hype.

Not guessing.

Not Discord rumors.

Filed ownership. Filed dates. Filed history.

And the history shows Dr. J did not do what people accused him of doing.

https://t.co/A6huqJy4Lo

$TXTM #TXTM #Form4 #Uplisting #RWA #Tokenization #Biotech #FilingsMatter

[PROTEXT MOBILITY INC. $TXTM @ProtextP]

Protext Mobility inc. $TXTM

🚨 QUIET TODAY. UNSTOPPABLE TOMORROW.

Most People Only Understand This After It Moves.

Not Because It Wasn’t Visible —
But Because They Didn’t Connect The Signals In Real Time.

$TXTM Has Just Added Another Verifiable Step:

A Live Filing On The U.S. Securities And Exchange Commission System.

Voluntary. Public. Traceable.

That’s Not Narrative.
That’s Execution Entering The Record.

Let’s Be Precise:

OTC Issuers Are Not Always Required To Operate Through EDGAR.

Many Don’t.

$TXTM Didn’t Just Signal Readiness —
It Demonstrated It Through Repeated Filing Activity.

Filed. Accepted. Logged.

That’s The Difference Between Intention
And Verifiable Compliance Execution.

Now Add What The Market Continues To Underweight:

Insider Alignment.

The Chairman Has Accumulated ~254M Common Shares
And Has Not Reduced That Position.

That’s Not Passive Exposure.
That’s Capital Aligned At The Top.

And The Pattern Continues:

Another Form 4 Filing Has Been Accepted Through EDGAR.

Extending A Continuous Insider Disclosure Footprint
Alongside Previously Reported Accumulation.

This Isn’t Isolated.

It’s Sequential.

What’s Building Here Isn’t Random — It’s Structural:

• EDGAR Filing Activity Active ✅
• Broadridge Infrastructure In Place ✅
• EDGAR Next Alignment In Progress ✅
• Ongoing Form 4 Transparency + Insider Positioning ✅

This Is What Early Structural Tightening Looks Like
Before The Market Reprices.

Here’s Where Most Misread The Phase:

They Wait For:
• Uplisting Headlines
• Analyst Coverage
• External Validation

But Markets Don’t Move On Announcements.

They Move On Confirmed Behaviour Already Embedded In Structure.

Since The Reverse Merger:

No Reverse Split Resets.
No Visible Dilution Cycle.
No Extraction-Driven Compensation Signals.

Combined With Insider Alignment
And Continuous Filing Activity—

This No Longer Fits A Typical OTC Profile.

This Is The Part Most Underestimate:

When Governance, Reporting Systems,
And Ownership Structure Tighten Together—

It Doesn’t Look Like Momentum.

It Looks Quiet.

Until It Isn’t.

The Market Won’t Announce The Re-Rate.

There’s No Bell.

One Day — It Simply Trades Differently.

$TXTM Isn’t Asking For Attention.

It’s Building A Verifiable Record —
Step By Step. Filing By Filing.

Position Accordingly.

Simunye. Ubuntu.

#TXTM #EDGAR #OTC #Uplisting #Execution

[Parabolic @Parabolicone]

$TXTM initial Form 4 filing on EDGAR voluntarily, and in historical context on 4-28-2026. This established that current management gained control in June 2022 through acquisition, drawing a clear line between present ownership and prior management:

SEC FORM 4 https://t.co/97K2Oy1G1m

Critically, that filing also confirms Dr. J did NOT hold any "common" shares from the time of acquisition, through the relevant period of CE. This directly contradicts claims circulated on X, Discord, and iHub alleging a “pump and dump.”

Today’s Form 4 also filed voluntarily and in historical context, further reinforces the record: no Series A, Series D, or any other shares were converted into common stock,before, during, or after the CE period:

SEC FORM 4 https://t.co/ycSJZOl22e

This is the key point: without ownership of common shares, there is no mechanism to sell, dilute, or benefit from a so-called "pump and dump".

These allegations were not only unfounded , they are now directly contradicted by official SEC filings. Mind you the manner in which these filings were submitted, while voluntary, allows the company to refrence them in future filings as matter of the factual record.

If I made false and baseless staments against the company in the public, statements that may have affected trading, I would be a little concerned that with all the things the company could have led with, they started with a factual representation directly refuting unsubstantiated public staments against the company.

Some staments were by posters who admittedly sold and are clearly salty they did. I hope they have proof of said allegations, because it certainly looks as if the company has told the truth and filed it with the SEC.

#TXTM is clearly setting the record straight and executing their plan, legally. If that makes you uncomfortable, I see that as a clear sign of who is on the right side of the law, and who, for whatever reason is perpetually is breaking it.

GLTU

[Parabolic @Parabolicone]

$TXTM initial Form 4 filing on EDGAR voluntarily, and in historical context on 4-28-2026. This established that current management gained control in June 2022 through acquisition, drawing a clear line between present ownership and prior management:

SEC FORM 4 https://t.co/97K2Oy1G1m

Critically, that filing also confirms Dr. J did NOT hold any "common" shares from the time of acquisition, through the relevant period of CE. This directly contradicts claims circulated on X, Discord, and iHub alleging a “pump and dump.”

Today’s Form 4 also filed voluntarily and in historical context, further reinforces the record: no Series A, Series D, or any other shares were converted into common stock,before, during, or after the CE period:

SEC FORM 4 https://t.co/ycSJZOl22e

This is the key point: without ownership of common shares, there is no mechanism to sell, dilute, or benefit from a so-called "pump and dump".

These allegations were not only unfounded , they are now directly contradicted by official SEC filings. Mind you the manner in which these filings were submitted, while voluntary, allows the company to refrence them in future filings as matter of the factual record.

If I made false and baseless staments against the company in the public, statements that may have affected trading, I would be a little concerned that with all the things the company could have led with, they started with a factual representation directly refuting unsubstantiated public staments against the company.

Some staments were by posters who admittedly sold and are clearly salty they did. I hope they have proof of said allegations, because it certainly looks as if the company has told the truth and filed it with the SEC.

#TXTM is clearly setting the record straight and executing their plan, legally. If that makes you uncomfortable, I see that as a clear sign of who is on the right side of the law, and who, for whatever reason is perpetually is breaking it.

GLTU

[Parabolic @Parabolicone]

Some people have simply never seen a biological asset company. TXTM is a fixed-cost business , a company with almost zero operational overhead and absolutely no debt. $TXTM also holds over half a billion dollars in debt-free, multiplying assets. Yet you still hear calls for revenue, when doing so would directly contradict our business model. Executing this asinine revenue model would be detrimental to the company at this stage.

If you sell half a billion worth of assets, you either take no deductions and Uncle Sam knocks on your door for a $250 million tax bill, or you lose half of your book value and all of your asset leverage. In what world does that make any business sense?

The right approach is to leverage those assets , use other people’s money to acquire more income-producing businesses or investments that pay for themselves. Leveraged or collateralized loans are not taxable.

So let this man build the company the right way, through profitable, exponential asset growth done correctly.

What would you even do with revenue that’s already lost 50 % of its value the moment you convert it to cash? TXTM has minimal employees, no rent, and no debt to service. The only logical next step is to keep multiplying assets , not give them away for free.

[Parabolic @Parabolicone]

@bigred993 There it is. Establishes proper controlling interest and ownership of TXTM in the public record. Extremely important disclosure. Lays the groundwork for some very interesting developments the company has been signaling.

[Parabolic @Parabolicone]

@SparticusDude Hes back!!

[Dr J @Dr_Jamaloodeen]

$TXTM
#TXTM

Web Push …

Join The Movement !!!

https://t.co/r3MxPxmW02

It ain’t if …